Disclosure of total number of voting rights and number of shares in the capital at November 30th, 2016

Sophia Antipolis, France

Pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.

Total number of shares 10,084,334
Number of real voting rights* (excluding treasury shares) 10,053,223
Theoritical number of voting rights* (including treasury shares**) 10,067,313


(*) Class B and E preference shares are non-voting
(**) pursuant to article 223-11 of the AMF’s General Regulations

Download PR_20161209_disclosure_total_number_voting_rights__shares_November_2016….pdf

About Median Technologies

alternext_almdt_modifiedMedian Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We leverage the power of Imaging Phenomics to provide insights into novel therapies and treatment strategies. Our unique solutions, LMS for lesion management and iBiopsy® for imaging phenotyping, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world to quickly and precisely bring new treatments to patients in need, with an eye on reducing overall care costs. This is how we are helping to create a healthier world.

Founded in 2002, based in Sophia-Antipolis, France, with a US subsidiary in Boston, Median has received the label “Innovative company” by the BPI and is listed on Euronext Paris’ Alternext market (ISIN: FR0011049824, ticker: ALMDT). The company is eligible for the PEA-PME SME equity savings plan setup and has received the label Pass French Tech Promotion 2016-2017. Median Technologies has been awarded the 2017 Tech 40 Label and has joined the EnterNext Tech 40 Index. Median is a member of the Bpifrance Excellence Network. More information: www.mediantechnologies.com

peapmelogo-pass-frt-a-promo2016-2017

 

 

 

 

Contacts

MEDIAN Technologies

Fredrik Brag
CEO
+33 4 92 90 65 82
fredrik.brag@mediantechnologies.com

Actifin (Investors)

Ghislaine Gasparetto
+33 1 56 88 11 11
ggasparetto@actifin.fr

Alizé RP (Press)

Caroline Carmagnol
Wendy Rigal
+33 1 44 54 36 66
median@alizerp.com